Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Feasibility of Outpatient High Dose Cytarabine in Patients with Acute Myeloid Leukemia

Chin-Hin NG, MD MRCP, FRCPATH, MCI, Xiaojuan Chen, BsN, MsN, Foong-Gwan Lee, BsN, Shi Hui Clarice Choong, MBBS, MRCP, Xiao-Shi Saw, BSc(Pharm), Lon-Wann Sai, MBBS, MRCP, Michelle Poon, MBBS, MRCP, FRCPATH, Hian Li Esther Hian Li Chan, MBBS, MRCP, FRCPATH, Melissa Ooi, MB BCh, BAO, MRCP(I), FRCPath, PhD, Yen Lin Chee, MBBS, FRCPATH, PhD, Yee Mei Lee, BsN, MsN, PhD

Blood (2019) 134 (Supplement_1): 2152.

https://doi.org/10.1182/blood-2019-129858

Published: 2019

Journal Articles

Clinical Manifestations and Prognostic Factors of Chronic Ocular Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Lan Y Wang, MD, Gloria B Chiu, OD, FAAO, FSLS, Rachel A Young, OD, Mojtaba Akhtari, MD

Blood (2018) 132 (Supplement 1): 5731.

https://doi.org/10.1182/blood-2018-99-119903

Published: 2018

Journal Articles

Deep and Durable Responses in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (MM) Treated with Monotherapy GSK2857916, an Antibody Drug Conjugate Against B-Cell Maturation Antigen (BCMA): Preliminary Results from Part 2 of Study BMA117159

Suzanne Trudel, MD FRCP(C), Nikoletta Lendvai, MD PhD, Rakesh Popat, MD PhD, Peter M. Voorhees, MD, Brandi Reeves, MD, Edward N. Libby, III, MD, Paul G Richardson, MD, Larry Anderson, MD PhD, Heather Sutherland, MD, Kwee Yong, PhD, Axel Hoos, MD PhD, Michele Gorczyca, MS, Soumi Lahiri, PhD, Zangdong He, PhD, Roxanne C Jewell, PhD, Joanna B. Opalinska, MD PhD, Adam D. Cohen, MD

Blood (2017) 130 (Supplement 1): 741.

https://doi.org/10.1182/blood.V130.Suppl_1.741.741

Published: 2017

Journal Articles

Ocular Graft-Versus Host Disease Prevention with Topical Cyclosporine in Non-Myeloablative Allogeneic Stem Cell Transplant

Rosa Elena Lozano-Morales, MD, Alberto Vázquez-Mellado de Larracoechea, Olga Cantu-Rodriguez, MD, Juan Luis Gonzalez-Treviño, Perla Rocío Colunga-Pedraza, MD, Miguel Angel Herrera-Rojas, MD, Monica Sánchez-Cárdenas, David Martínez-Garza, Daniela Michelle Pérez-Garza, David Gomez-Almaguer, MD

Blood (2016) 128 (22): 4569.

https://doi.org/10.1182/blood.V128.22.4569.4569

Published: 2016

Journal Articles

Unique Patterns of Lymphocyte Recovery Induced By Hyperbaric Oxygen Therapy Given Prior to Stem Cell Transplantation: A Case Series Report on Three Patients

Haitham Abdelhakim, MD, Leyla Shune, MD, Da Zhang, MD, Omar S. Aljitawi, MD

Blood (2015) 126 (23): 5488.

https://doi.org/10.1182/blood.V126.23.5488.5488

Published: 2015

Journal Articles

Characteristics of "Older Old" Patients with Sickle Cell Anemia Who Survived for More Than 80 Years

Dianne Pulte, MD, Gaye Riddick-Burden, MSN, Samir K. Ballas, MD

Blood (2015) 126 (23): 4599.

https://doi.org/10.1182/blood.V126.23.4599.4599

Published: 2015

Journal Articles

Safety & Efficacy of Human Plasma Derived Plasminogen Ophthalmic Drops for Treatment of Ligneous Conjunctivitis: Report of Phase 2/3 Clinical Trial

Charles T Nakar, MD, Roberto Caputo, MD, Francis W Price, Jr., MD, Maria Teresa Sartori, MD, Andrea Leonardi, Anna Lotti Suffredini, Neelam Thukral, Jacopo Secci, Bennie H Jeng, MD, Amy D Shapiro, MD

Blood (2015) 126 (23): 2288.

https://doi.org/10.1182/blood.V126.23.2288.2288

Published: 2015

Journal Articles

Interim Analysis of a Phase 1 Study of the Antibody-Drug Conjugate SGN-CD19A in Relapsed or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

Amir T Fathi, Robert Chen, MD, Tanya M. Trippett, Maureen M. O'Brien, MD, Daniel J DeAngelo, Bijal D. Shah, MD, Todd M. Cooper, DO, James M. Foran, MD, Gregory A. Hale, MD, Joseph Pressey, MD, Lewis B. Silverman, Raoul Tibes, MD, Stella Kim, MD, Tina M. Albertson, MD PhD, Larissa Sandalic, MS, Baiteng Zhao, PhD, Uma Borate, MD

Blood (2014) 124 (21): 963.

https://doi.org/10.1182/blood.V124.21.963.963

Published: 2014

Journal Articles

Interim Analysis of a Phase 1 Study of the Antibody-Drug Conjugate SGN-CD19A in Relapsed or Refractory B-Lineage Non-Hodgkin Lymphoma

Craig H. Moskowitz, MD, Andres Forero-Torres, MD, Bijal D. Shah, MD, Ranjana Advani, MD, Paul Hamlin, MD, Stella Kim, MD, Ana Kostic, MD, Larissa Sandalic, MS, Baiteng Zhao, PhD, Michelle A. Fanale, MD

Blood (2014) 124 (21): 1741.

https://doi.org/10.1182/blood.V124.21.1741.1741

Published: 2014

Journal Articles

Autologous Serum Containing Platelet Derived Growth Factors (PDGFs) as Topical Treatment for “Sicca Syndrome” Associated with Chronic GvHD.

Del Fante Claudia, MD, Perotti Cesare, MD, Viarengo Gianluca, MD, Marchesi Andrea, Parisi Cristina, Bergamaschi Paola, MD, Salvaneschi Laura, MD

Blood (2006) 108 (11): 2864.

https://doi.org/10.1182/blood.V108.11.2864.2864

Published: 2006

Journal Articles

Rituximab Plus Hypercvad (R-HCVAD) Alternating with Rituximab Plus High-Dose Methotrexate-Cytarabine (R-M/A) in Untreated Mantle Cell Lymphoma (MCL): Prolonged Follow-Up Confirms High Rates of Failure-Free Survival (FFS) and Overall Survival (OS).

Jorge Enrique Romaguera, MD, Luis Fayad, MD, Maria A. Rodriguez, MD, Fredrick B. Hagemeister, MD, Barbara Pro, MD, Peter McLaughlin, MD, Anas Younes, MD, Felipe Samaniego, MD, Andre Goy, MD, Andreas H. Sarris, MD, Ph.D., Nam H. Dang, MD, Ph.D., L. Jeffrey Medeiros, MD, Ruth Katz, MD, Harish Gagneja, MD, Barry I. Samuels, MD, Fernando Cabanillas, MD

Blood (2004) 104 (11): 128.

https://doi.org/10.1182/blood.V104.11.128.128

Published: 2004

NARROW

Feasibility of Outpatient High Dose Cytarabine in Patients with Acute Myeloid Leukemia

Clinical Manifestations and Prognostic Factors of Chronic Ocular Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Deep and Durable Responses in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (MM) Treated with Monotherapy GSK2857916, an Antibody Drug Conjugate Against B-Cell Maturation Antigen (BCMA): Preliminary Results from Part 2 of Study BMA117159

Ocular Graft-Versus Host Disease Prevention with Topical Cyclosporine in Non-Myeloablative Allogeneic Stem Cell Transplant

Unique Patterns of Lymphocyte Recovery Induced By Hyperbaric Oxygen Therapy Given Prior to Stem Cell Transplantation: A Case Series Report on Three Patients

Characteristics of "Older Old" Patients with Sickle Cell Anemia Who Survived for More Than 80 Years

Safety & Efficacy of Human Plasma Derived Plasminogen Ophthalmic Drops for Treatment of Ligneous Conjunctivitis: Report of Phase 2/3 Clinical Trial

Interim Analysis of a Phase 1 Study of the Antibody-Drug Conjugate SGN-CD19A in Relapsed or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

Interim Analysis of a Phase 1 Study of the Antibody-Drug Conjugate SGN-CD19A in Relapsed or Refractory B-Lineage Non-Hodgkin Lymphoma

Autologous Serum Containing Platelet Derived Growth Factors (PDGFs) as Topical Treatment for “Sicca Syndrome” Associated with Chronic GvHD.

Rituximab Plus Hypercvad (R-HCVAD) Alternating with Rituximab Plus High-Dose Methotrexate-Cytarabine (R-M/A) in Untreated Mantle Cell Lymphoma (MCL): Prolonged Follow-Up Confirms High Rates of Failure-Free Survival (FFS) and Overall Survival (OS).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only